IBDEI16L ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,19166,0)
;;=J45.52^^64^851^30
;;^UTILITY(U,$J,358.3,19166,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19166,1,3,0)
;;=3^Severe Persistent Asthma w/ Status Asthmaticus
;;^UTILITY(U,$J,358.3,19166,1,4,0)
;;=4^J45.52
;;^UTILITY(U,$J,358.3,19166,2)
;;=^5008253
;;^UTILITY(U,$J,358.3,19167,0)
;;=J45.50^^64^851^31
;;^UTILITY(U,$J,358.3,19167,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19167,1,3,0)
;;=3^Severe Persistent Asthma,Uncomplicated
;;^UTILITY(U,$J,358.3,19167,1,4,0)
;;=4^J45.50
;;^UTILITY(U,$J,358.3,19167,2)
;;=^5008251
;;^UTILITY(U,$J,358.3,19168,0)
;;=J43.0^^64^851^32
;;^UTILITY(U,$J,358.3,19168,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19168,1,3,0)
;;=3^Unilateral Pulmonary Emphysema
;;^UTILITY(U,$J,358.3,19168,1,4,0)
;;=4^J43.0
;;^UTILITY(U,$J,358.3,19168,2)
;;=^5008235
;;^UTILITY(U,$J,358.3,19169,0)
;;=J45.901^^64^851^3
;;^UTILITY(U,$J,358.3,19169,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19169,1,3,0)
;;=3^Asthma w/ Exacerbation,Unspec
;;^UTILITY(U,$J,358.3,19169,1,4,0)
;;=4^J45.901
;;^UTILITY(U,$J,358.3,19169,2)
;;=^5008254
;;^UTILITY(U,$J,358.3,19170,0)
;;=J45.902^^64^851^4
;;^UTILITY(U,$J,358.3,19170,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19170,1,3,0)
;;=3^Asthma w/ Status Asthmaticus,Unspec
;;^UTILITY(U,$J,358.3,19170,1,4,0)
;;=4^J45.902
;;^UTILITY(U,$J,358.3,19170,2)
;;=^5008255
;;^UTILITY(U,$J,358.3,19171,0)
;;=J45.909^^64^851^5
;;^UTILITY(U,$J,358.3,19171,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19171,1,3,0)
;;=3^Asthma,Uncomplicated,Unspec
;;^UTILITY(U,$J,358.3,19171,1,4,0)
;;=4^J45.909
;;^UTILITY(U,$J,358.3,19171,2)
;;=^5008256
;;^UTILITY(U,$J,358.3,19172,0)
;;=J42.^^64^851^13
;;^UTILITY(U,$J,358.3,19172,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19172,1,3,0)
;;=3^Chr Bronchitis,Unspec
;;^UTILITY(U,$J,358.3,19172,1,4,0)
;;=4^J42.
;;^UTILITY(U,$J,358.3,19172,2)
;;=^5008234
;;^UTILITY(U,$J,358.3,19173,0)
;;=I95.1^^64^852^1
;;^UTILITY(U,$J,358.3,19173,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19173,1,3,0)
;;=3^Orthostatic Hypotension
;;^UTILITY(U,$J,358.3,19173,1,4,0)
;;=4^I95.1
;;^UTILITY(U,$J,358.3,19173,2)
;;=^60741
;;^UTILITY(U,$J,358.3,19174,0)
;;=I73.9^^64^852^2
;;^UTILITY(U,$J,358.3,19174,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19174,1,3,0)
;;=3^Peripheral Vascular Disease,Unspec
;;^UTILITY(U,$J,358.3,19174,1,4,0)
;;=4^I73.9
;;^UTILITY(U,$J,358.3,19174,2)
;;=^184182
;;^UTILITY(U,$J,358.3,19175,0)
;;=I80.13^^64^852^3
;;^UTILITY(U,$J,358.3,19175,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19175,1,3,0)
;;=3^Phlebitis/Thromophlebitis Bilateral Femoral Vein
;;^UTILITY(U,$J,358.3,19175,1,4,0)
;;=4^I80.13
;;^UTILITY(U,$J,358.3,19175,2)
;;=^5007827
;;^UTILITY(U,$J,358.3,19176,0)
;;=I80.213^^64^852^4
;;^UTILITY(U,$J,358.3,19176,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19176,1,3,0)
;;=3^Phlebitis/Thromophlebitis Bilateral Iliac Vein
;;^UTILITY(U,$J,358.3,19176,1,4,0)
;;=4^I80.213
;;^UTILITY(U,$J,358.3,19176,2)
;;=^5007833
;;^UTILITY(U,$J,358.3,19177,0)
;;=I80.223^^64^852^7
;;^UTILITY(U,$J,358.3,19177,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19177,1,3,0)
;;=3^Phlebitis/Thromophlebitis Bilateral Popliteal Vein
;;^UTILITY(U,$J,358.3,19177,1,4,0)
;;=4^I80.223
;;^UTILITY(U,$J,358.3,19177,2)
;;=^5007837
;;^UTILITY(U,$J,358.3,19178,0)
;;=I80.233^^64^852^8
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI16L 3764 printed Apr 09, 2024@21:53:06 Page 2
IBDEI16L ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,19166,0)
+2 ;;=J45.52^^64^851^30
+3 ;;^UTILITY(U,$J,358.3,19166,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,19166,1,3,0)
+6 ;;=3^Severe Persistent Asthma w/ Status Asthmaticus
+7 ;;^UTILITY(U,$J,358.3,19166,1,4,0)
+8 ;;=4^J45.52
+9 ;;^UTILITY(U,$J,358.3,19166,2)
+10 ;;=^5008253
+11 ;;^UTILITY(U,$J,358.3,19167,0)
+12 ;;=J45.50^^64^851^31
+13 ;;^UTILITY(U,$J,358.3,19167,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,19167,1,3,0)
+16 ;;=3^Severe Persistent Asthma,Uncomplicated
+17 ;;^UTILITY(U,$J,358.3,19167,1,4,0)
+18 ;;=4^J45.50
+19 ;;^UTILITY(U,$J,358.3,19167,2)
+20 ;;=^5008251
+21 ;;^UTILITY(U,$J,358.3,19168,0)
+22 ;;=J43.0^^64^851^32
+23 ;;^UTILITY(U,$J,358.3,19168,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,19168,1,3,0)
+26 ;;=3^Unilateral Pulmonary Emphysema
+27 ;;^UTILITY(U,$J,358.3,19168,1,4,0)
+28 ;;=4^J43.0
+29 ;;^UTILITY(U,$J,358.3,19168,2)
+30 ;;=^5008235
+31 ;;^UTILITY(U,$J,358.3,19169,0)
+32 ;;=J45.901^^64^851^3
+33 ;;^UTILITY(U,$J,358.3,19169,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,19169,1,3,0)
+36 ;;=3^Asthma w/ Exacerbation,Unspec
+37 ;;^UTILITY(U,$J,358.3,19169,1,4,0)
+38 ;;=4^J45.901
+39 ;;^UTILITY(U,$J,358.3,19169,2)
+40 ;;=^5008254
+41 ;;^UTILITY(U,$J,358.3,19170,0)
+42 ;;=J45.902^^64^851^4
+43 ;;^UTILITY(U,$J,358.3,19170,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,19170,1,3,0)
+46 ;;=3^Asthma w/ Status Asthmaticus,Unspec
+47 ;;^UTILITY(U,$J,358.3,19170,1,4,0)
+48 ;;=4^J45.902
+49 ;;^UTILITY(U,$J,358.3,19170,2)
+50 ;;=^5008255
+51 ;;^UTILITY(U,$J,358.3,19171,0)
+52 ;;=J45.909^^64^851^5
+53 ;;^UTILITY(U,$J,358.3,19171,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,19171,1,3,0)
+56 ;;=3^Asthma,Uncomplicated,Unspec
+57 ;;^UTILITY(U,$J,358.3,19171,1,4,0)
+58 ;;=4^J45.909
+59 ;;^UTILITY(U,$J,358.3,19171,2)
+60 ;;=^5008256
+61 ;;^UTILITY(U,$J,358.3,19172,0)
+62 ;;=J42.^^64^851^13
+63 ;;^UTILITY(U,$J,358.3,19172,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,19172,1,3,0)
+66 ;;=3^Chr Bronchitis,Unspec
+67 ;;^UTILITY(U,$J,358.3,19172,1,4,0)
+68 ;;=4^J42.
+69 ;;^UTILITY(U,$J,358.3,19172,2)
+70 ;;=^5008234
+71 ;;^UTILITY(U,$J,358.3,19173,0)
+72 ;;=I95.1^^64^852^1
+73 ;;^UTILITY(U,$J,358.3,19173,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,19173,1,3,0)
+76 ;;=3^Orthostatic Hypotension
+77 ;;^UTILITY(U,$J,358.3,19173,1,4,0)
+78 ;;=4^I95.1
+79 ;;^UTILITY(U,$J,358.3,19173,2)
+80 ;;=^60741
+81 ;;^UTILITY(U,$J,358.3,19174,0)
+82 ;;=I73.9^^64^852^2
+83 ;;^UTILITY(U,$J,358.3,19174,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,19174,1,3,0)
+86 ;;=3^Peripheral Vascular Disease,Unspec
+87 ;;^UTILITY(U,$J,358.3,19174,1,4,0)
+88 ;;=4^I73.9
+89 ;;^UTILITY(U,$J,358.3,19174,2)
+90 ;;=^184182
+91 ;;^UTILITY(U,$J,358.3,19175,0)
+92 ;;=I80.13^^64^852^3
+93 ;;^UTILITY(U,$J,358.3,19175,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,19175,1,3,0)
+96 ;;=3^Phlebitis/Thromophlebitis Bilateral Femoral Vein
+97 ;;^UTILITY(U,$J,358.3,19175,1,4,0)
+98 ;;=4^I80.13
+99 ;;^UTILITY(U,$J,358.3,19175,2)
+100 ;;=^5007827
+101 ;;^UTILITY(U,$J,358.3,19176,0)
+102 ;;=I80.213^^64^852^4
+103 ;;^UTILITY(U,$J,358.3,19176,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,19176,1,3,0)
+106 ;;=3^Phlebitis/Thromophlebitis Bilateral Iliac Vein
+107 ;;^UTILITY(U,$J,358.3,19176,1,4,0)
+108 ;;=4^I80.213
+109 ;;^UTILITY(U,$J,358.3,19176,2)
+110 ;;=^5007833
+111 ;;^UTILITY(U,$J,358.3,19177,0)
+112 ;;=I80.223^^64^852^7
+113 ;;^UTILITY(U,$J,358.3,19177,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,19177,1,3,0)
+116 ;;=3^Phlebitis/Thromophlebitis Bilateral Popliteal Vein
+117 ;;^UTILITY(U,$J,358.3,19177,1,4,0)
+118 ;;=4^I80.223
+119 ;;^UTILITY(U,$J,358.3,19177,2)
+120 ;;=^5007837
+121 ;;^UTILITY(U,$J,358.3,19178,0)
+122 ;;=I80.233^^64^852^8
